Intravitreal Aflibercept Injection (IAI) for Presumed Ocular Histoplasmosis Syndrome
Clinical trial NCT01578720 · COMPLETED
Trial details
- NCT number
- NCT01578720
- Sponsor
- Retina Research Institute, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2014-04-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.